SWM
ABBV icon

Stonebridge Wealth Management’s AbbVie ABBV Stock Holding History

Stonebridge Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.46M Buy
13,218
+1
+0% +$256 3.08% 9
2026
Q2 		$3.33M Sell
13,217
-13
-0.1% -$2.8K 2.98% 10
2026
Q1 		$2.88M Buy
13,230
+13
+0.1% +$2.88K 2.76% 10
2025
Q4 		$3.02M Sell
13,217
-49
-0.4% -$11.2K 2.85% 11
2025
Q3 		$3.07M Hold
13,266
– – 2.64% 14
2025
Q2 		$2.46M Buy
+13,266
New +$2.47M 2.32% 12

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Stonebridge Wealth Management's ABBV Position: Q3 2026 in Review

Stonebridge Wealth Management increased its AbbVie (ABBV) stake by 0.01% in Q3 2026, buying an estimated $256 and bringing the position to 13,218 shares worth $3.46M. The position accounts for 3.08% of the portfolio, ranked #9.

Stonebridge Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 6 quarters since. 1,083 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Stonebridge Wealth Management held 13,218 shares of AbbVie worth $3.46M as of Q3 2026.
  • Stonebridge Wealth Management bought 1 AbbVie share in Q3 2026, an estimated $256.
  • AbbVie made up 3.08% of Stonebridge Wealth Management's portfolio in Q3 2026, its #9 holding.
  • Stonebridge Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 6 quarters since.
  • 1,083 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Stonebridge Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.